Clinical trials recruiting in Hiratsuka-shi, Japan

Phase breakdown

Conditions recruiting in Hiratsuka-shi, Japan

Recruiting trials in Hiratsuka-shi, Japan

• A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
  NCT06935370 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
  NCT06424288 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
  NCT06894212 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Hiratsuka-shi, Japan?

3 recruiting trials have at least one study site in Hiratsuka-shi, Japan.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.